SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER - ANVISA Registration 80146502386

Access comprehensive regulatory information for SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80146502386 and manufactured by ABBOTT DIABETES CARE LTD. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Sep 04, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SHENZHEN SISENSING CO., LTD., MICROTECH MEDICAL (HANGZHOU) CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.